# U2AF2 controls alternative splicing in speckle-proximal regions in an RS domain-dependent manner

**Authors:** Serhii Pankivskyi, Asaki Kobayashi, Jean de Matha Salone, Kimberley Gargoly, David Pastré, Alexandre Maucuer

PMC · DOI: 10.1093/nar/gkag143 · Nucleic Acids Research · 2026-02-28

## TL;DR

The study reveals how the splicing factor U2AF2 regulates alternative splicing near nuclear speckles, with its RS domain playing a key role in this process.

## Contribution

The novel finding is that U2AF2's RS domain mediates its localization and function in splicing, particularly in speckle-proximal regions.

## Key findings

- U2AF2's RS domain is essential for its self-association and localization to nuclear speckles.
- Splicing is most affected in genes near speckles when U2AF2 is reduced or its RS domain is removed.
- Phosphorylation sites in the RS domain are required for normal splicing regulation.

## Abstract

Splicing factor U2AF2 is known to play a pivotal role for 3′ splice site recognition at an early step of spliceosome assembly. Here, using proximity labeling and biochemical confirmations, we extend the repertoire of putative functional partners of U2AF2 mainly for splicing, chromatin modification, transcription, 3′ end processing, and RNA methylation. Removal of the U2AF2 RS domain alters numerous interactions, including self-association, reduces its localization to nuclear speckles, and impacts splicing genome-wide in a manner that depends both on splicing signals and on intron length. Indeed, cassette exon flanked by short introns in genes or transcripts located close to speckles are the most affected by U2AF2 knockdown or RS domain removal. Finally, we show that phosphorylation sites within the U2AF2 RS domain are required for normal splicing, suggesting that its RS domain mediates U2AF2 regulation. Our in-depth bioinformatics analyses reinforce previous observations that alternatively spliced transcripts accumulate in the proximity of speckles. Our results suggest that although U2AF2 is clearly enriched in these regions, its local concentration remains limiting. Consequently, a global reduction in U2AF2 disproportionately affects splicing in the vicinity of nuclear speckles. This provides new insight into how spatial protein availability contributes to the regulation of alternative splicing.

Graphical Abstract

## Linked entities

- **Genes:** U2AF2 (U2 small nuclear RNA auxiliary factor 2) [NCBI Gene 11338]
- **Proteins:** U2AF2 (U2 small nuclear RNA auxiliary factor 2)

## Full-text entities

- **Genes:** RTF1 (RTF1 homolog, Paf1/RNA polymerase II complex component) [NCBI Gene 23168] {aka GTL7, KIAA0252}, SRSF9 (serine and arginine rich splicing factor 9) [NCBI Gene 8683] {aka SFRS9, SRp30c}, SLIT2 (slit guidance ligand 2) [NCBI Gene 9353] {aka SLIL3, Slit-2}, LINC02605 (long intergenic non-protein coding RNA 2605) [NCBI Gene 112935892] {aka AS, IL-7, IL-7-AS}, POLR2A (RNA polymerase II subunit A) [NCBI Gene 5430] {aka NEDHIB, POLR2, POLRA, RPB1, RPBh1, RPO2}, CPSF7 (cleavage and polyadenylation specific factor 7) [NCBI Gene 79869] {aka CFIm59}, CTD (Coats disease) [NCBI Gene 1283], SCAF1 (SR-related CTD associated factor 1) [NCBI Gene 58506] {aka SRA1}, SRRM2 (serine/arginine repetitive matrix 2) [NCBI Gene 23524] {aka 300-KD, CWF21, Cwc21, HSPC075, MRD72, SRL300}, SETD2 (SET domain containing 2, histone lysine methyltransferase) [NCBI Gene 29072] {aka HBP231, HIF-1, HIP-1, HSPC069, HYPB, KMT3A}, SRPK1 (SRSF protein kinase 1) [NCBI Gene 6732] {aka SFRSK1}, SNRNP70 (small nuclear ribonucleoprotein U1 subunit 70) [NCBI Gene 6625] {aka RNPU1Z, RPU1, SNRP70, Snp1, U1-70K, U170K}, PRDM9 (PR/SET domain 9) [NCBI Gene 56979] {aka KMT8B, MEISETZ, MSBP3, PFM6, ZNF899}, U2af50 (U2 small nuclear riboprotein auxiliary factor 50) [NCBI Gene 32602] {aka 9-21, CG9998, DU2AF50, DmU2AF[50], Dmel\CG9998, U2AF}, RBM10 (RNA binding motif protein 10) [NCBI Gene 8241] {aka DXS8237E, GPATC9, GPATCH9, MINAS-60, S1-1, TARPS}, CHERP (calcium homeostasis endoplasmic reticulum protein) [NCBI Gene 10523] {aka DAN16, SCAF6}, CPSF6 (cleavage and polyadenylation specific factor 6) [NCBI Gene 11052] {aka CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7}, U2SURP (U2 snRNP associated SURP domain containing) [NCBI Gene 23350] {aka SR140, fSAPa}, SRSF10 (serine and arginine rich splicing factor 10) [NCBI Gene 10772] {aka FUSIP1, FUSIP2, NSSR, PPP1R149, SFRS13, SFRS13A}, SAP30BP (SAP30 binding protein) [NCBI Gene 29115] {aka HCNGP, HTRG, HTRP}, PCF11 (PCF11 cleavage and polyadenylation factor subunit) [NCBI Gene 51585], CDC73 (cell division cycle 73) [NCBI Gene 79577] {aka C1orf28, FIHP, HPTJT, HRPT1, HRPT2, HYX}, SRSF1 (serine and arginine rich splicing factor 1) [NCBI Gene 6426] {aka ASF, NEDFBA, SF2, SF2p33, SFRS1, SRp30a}, PCLAF (PCNA clamp associated factor) [NCBI Gene 9768] {aka KIAA0101, L5, NS5ATP9, OEATC, OEATC-1, OEATC1}, PRPF3 (pre-mRNA processing factor 3) [NCBI Gene 9129] {aka HPRP3, HPRP3P, PRP3, Prp3p, RP18, SNRNP90}, ZC3H18 (zinc finger CCCH-type containing 18) [NCBI Gene 124245] {aka NHN1}, SF3B1 (splicing factor 3b subunit 1) [NCBI Gene 23451] {aka Hsh155, MDS, PRP10, PRPF10, SAP155, SF3b155}, PRPF40A (pre-mRNA processing factor 40A) [NCBI Gene 55660] {aka FBP-11, FBP11, FLAF1, FNBP3, HIP-10, HIP10}, FUS (FUS RNA binding protein) [NCBI Gene 2521] {aka ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS}, DVL1 (dishevelled segment polarity protein 1) [NCBI Gene 1855] {aka DRS2, DVL, DVL1L1}, SRSF2 (serine and arginine rich splicing factor 2) [NCBI Gene 6427] {aka PR264, SC-35, SC35, SFRS2, SFRS2A, SRp30b}, SF1 (splicing factor 1) [NCBI Gene 7536] {aka BBP, D11S636, MBBP, ZCCHC25, ZFM1, ZNF162}, TRIM27 (tripartite motif containing 27) [NCBI Gene 5987] {aka RFP, RNF76}, RRM2 (ribonucleotide reductase regulatory subunit M2) [NCBI Gene 6241] {aka C2orf48, R2, RR2, RR2M}, THRAP3 (thyroid hormone receptor associated protein 3) [NCBI Gene 9967] {aka BCLAF2, TRAP150}, BCLAF1 (BCL2 associated transcription factor 1) [NCBI Gene 9774] {aka BTF, bK211L9.1}, CCAR1 (cell division cycle and apoptosis regulator 1) [NCBI Gene 55749] {aka uc.285+}, PAF1 (PAF1 component of Paf1/RNA polymerase II complex) [NCBI Gene 54623] {aka F23149_1, PD2}, WDR33 (WD repeat domain 33) [NCBI Gene 55339] {aka NET14, WDC146}, PAPOLA (poly(A) polymerase alpha) [NCBI Gene 10914] {aka PAP, PAP-alpha}, ECI2 (enoyl-CoA delta isomerase 2) [NCBI Gene 10455] {aka ACBD2, DRS-1, DRS1, HCA88, PECI, dJ1013A10.3}, U2AF2 (U2 small nuclear RNA auxiliary factor 2) [NCBI Gene 11338] {aka DEVDFB, U2AF65}, KHDRBS1 (KH RNA binding domain containing, signal transduction associated 1) [NCBI Gene 10657] {aka Sam68, p62, p68}, MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938] {aka HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, miPEP-52}, RBM39 (RNA binding motif protein 39) [NCBI Gene 9584] {aka CAPER, CAPERalpha, FSAP59, HCC1, RNPC2}, RPRD2 (regulation of nuclear pre-mRNA domain containing 2) [NCBI Gene 23248] {aka HSPC099, KIAA0460}, SNRNP200 (small nuclear ribonucleoprotein U5 subunit 200) [NCBI Gene 23020] {aka ASCC3L1, BRR2, HELIC2, RP33, U5-200KD}, NONO (non-POU domain containing octamer binding) [NCBI Gene 4841] {aka MRXS34, NMT55, NRB54, P54, P54NRB, PPP1R114}, RBP1 (retinol binding protein 1) [NCBI Gene 5947] {aka CRABP-I, CRBP, CRBP1, CRBPI, RBPC, hCRBP1}, ARFIP2 (ARF interacting protein 2) [NCBI Gene 23647] {aka POR1}, PUF60 (poly(U) binding splicing factor 60) [NCBI Gene 22827] {aka FIR, RoBPI, SIAHBP1, VRJS}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, SUGP1 (SURP and G-patch domain containing 1) [NCBI Gene 57794] {aka F23858, RBP, SF4}, U2AF1 (U2 small nuclear RNA auxiliary factor 1) [NCBI Gene 7307] {aka FP793, RN, RNU2AF1, U2AF35, U2AFBP}, TRC-GCA24-1 (tRNA-Cys (GCA) 24-1) [NCBI Gene 7183] {aka TRC, TRNAC1}, SON (SON DNA and RNA binding protein) [NCBI Gene 6651] {aka BASS1, C21orf50, DBP-5, NREBP, SON3, TOKIMS}, SRSF7 (serine and arginine rich splicing factor 7) [NCBI Gene 6432] {aka 9G8, AAG3, SFRS7}, DDX42 (DEAD-box helicase 42) [NCBI Gene 11325] {aka DDX42P, RHELP, RNAHP, SF3B8, SF3b125}, APEX2 (apurinic/apyrimidinic endodeoxyribonuclease 2) [NCBI Gene 27301] {aka APE2, APEXL2, XTH2, ZGRF2}, FUBP1 (far upstream element binding protein 1) [NCBI Gene 8880] {aka FBP, FUBP, hDH V}
- **Diseases:** hepatocellular carcinoma (MESH:D006528), infection (MESH:D007239), colorectal carcinoma (MESH:D015179), chronic myelogenous leukemia (MESH:D015464), cervical adenocarcinoma (MESH:D000230), cancer (MESH:D009369)
- **Chemicals:** polyA (MESH:D011061), 4',6-diamidino-2-phenylindole (MESH:C007293), Coomassie blue (MESH:C048139), AS (MESH:D001151), sodium acetate (MESH:D019346), lysine (MESH:D008239), agarose (MESH:D012685), polybrene (MESH:D006583), PFA (MESH:C003043), cysteine (MESH:D003545), RS (MESH:D000084922), glutathione (MESH:D005978), CO2 (MESH:D002245), RA (MESH:D011883), ATP (MESH:D000255), serine (MESH:D012694), trifluoroacetic acid (MESH:D014269), amines (MESH:D000588), MTT (MESH:C070243), aspartic acid (MESH:D001224), Lipofectamine 2000 (MESH:C086724), PMSF (MESH:D010664), puromycin (MESH:D011691), KS (MESH:D011188), 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MESH:C022616), DMEM (-), dipeptides (MESH:D004151), acrylamide (MESH:D020106), SDS (MESH:D012967), acetic acid (MESH:D019342), biotin (MESH:D001710), DTT (MESH:D004229), iodoacetamide (MESH:D007460), peptides (MESH:D010455), water (MESH:D014867), Polyacrylamide (MESH:C016679), alanine (MESH:D000409), acetonitrile (MESH:C032159), Triton X-100 (MESH:D017830), EDTA (MESH:D004492), NP-40 (MESH:C010615), formic acid (MESH:C030544), methanol (MESH:D000432), NaCl (MESH:D012965), sodium deoxycholate (MESH:D003840)
- **Species:** Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** deletion of aa 1-92, Ser-Pro, R-to-K, arginine-serine, Arginine residues were mutated to alanine, S-to-A, R452D, S-to-D
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), BioID2 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_C0QG), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HFF — Homo sapiens (Human), Finite cell line (CVCL_3285), U2AF2-dRS — Mus musculus (Mouse), Hybridoma (CVCL_KM54), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), hESC — Homo sapiens (Human), Embryonic stem cell (CVCL_9771)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956353/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956353/full.md

## References

109 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956353/full.md

---
Source: https://tomesphere.com/paper/PMC12956353